SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunoGen
IMGN 31.230.0%Feb 26 3:00 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
Area51
From: Gary Mohilner10/25/2022 6:50:03 PM
1 Recommendation  Read Replies (1) of 5665
 
I'm of the belief that the FDA is quite familiar with MIRV and that they will approve it. Because of their prior familiarity with it, I believe we're now in a window in which the approval could come any day in that we're essentially just over a month before their PDUFA date. Approval should certainly take our share price into double digits and as more information comes out on other drugs at ASH and perhaps other conference I think it will go higher.

Gary
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News